A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)
Phase of Trial: Phase I/II
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Enzalutamide (Primary) ; Indometacin
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2018 According to a trial design presented at 2018 Genitourinary Cancers Symposium, 4 patients have been enrolled.
- 10 Feb 2018 Trial design presented at the 2018 Genitourinary Cancers Symposium.
- 30 Oct 2017 Status changed from not yet recruiting to recruiting.